Ligand validation:3HSN

HAR: N-OMEGA-HYDROXY-L-ARGININE

HAR is a Ligand Of Interest in 3HSN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HSN_HAR_A_770	64%	23%	0.171	0.97	1.72	1.48	2	1	0	0	100%	1
3HSN_HAR_B_1770	63%	30%	0.176	0.974	1.76	1.04	2	-	0	0	100%	1
3HSP_HAR_B_1770	97%	33%	0.065	0.981	1.71	0.98	1	-	0	0	100%	1
3HSO_HAR_A_770	86%	15%	0.109	0.978	1.77	2	2	2	0	0	100%	1
1LZX_HAR_B_1770	57%	47%	0.182	0.957	1.23	0.84	1	-	0	0	100%	1
3LP7_HAR_A_906	85%	2%	0.103	0.968	2.21	4.27	4	5	0	0	100%	1
4Q3T_HAR_C_405	79%	14%	0.114	0.96	2.27	1.64	2	3	1	0	100%	0.5
5VKA_HAR_A_403	78%	33%	0.096	0.937	1.43	1.21	1	1	0	0	100%	0.89

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.